Our Human PBMC-B Mouse Model successfully reconstructs human B cells within immunodeficient mice. This enables the simulation of human immune responses that include human-specific antibody production, a critical feature often missing in other humanized models.
Human PBMC-B Mouse Model Service for Immuno-Oncology Study
Creative Biolabs offers a comprehensive, rapid-turnaround platform for preclinical immuno-oncology research. We provide fully custom-designed studies utilizing ultra-immunodeficient mice reconstituted with functional human T-cells and B-cells. Clients can expect to gain high-fidelity, full-spectrum efficacy and safety data (cellular and humoral) on their research compounds, significantly accelerating the validation and development of their immunotherapy lead candidates.
Introduction What We Can Offer How We Can Help Why Creative Biolabs Customer Reviews FAQs Related Services Contact Us
Advancing Immuno-Oncology with Humanized B Cell Models
The advent of immunotherapy has revolutionized the landscape of cancer treatment, offering promise for malignancies that were previously deemed incurable. However, the translation of immunotherapeutic agents from bench to bedside faces significant hurdles due to species-specific differences in preclinical models. Humanized mouse models, particularly those utilizing human peripheral blood mononuclear cells (PBMCs), provide an invaluable platform for investigating human immune responses in tumor immunology. Creative Biolabs has developed the innovative human PBMC-B mouse model to overcome these challenges and enhance the study of immuno-oncology in a clinically relevant manner.
Initiate scientific consultation to explore Creative Biolabs' service capabilities.
Fig.1 Schematic representation of immunodeficient mouse models and humanization strategies used to establish preclinical models. 1
What We Can Offer
Creative Biolabs offers a proprietary human PBMC-B mouse model designed explicitly for the pre-clinical evaluation of tumor immunotherapies and autoimmune disease drugs. This model addresses the limitations of traditional PBMC and CD34+ hematopoietic stem cell (HSC) models by incorporating human antibody involvement in immune responses, thereby providing a more comprehensive and realistic system for immunotherapy research.
Human B-Cell Reconstruction
Enhanced Antibody Functionality
Compared to traditional CD34+ HSC models, the reconstructed B cells in our model possess active antibody secretion functionality. This enhancement generates richer and more relevant data for immuno-oncology research, making it an invaluable tool for researchers.
Complete Humoral Immunity Process
In conjunction with our human myeloid cell reconstruction model, the Human PBMC-B Mouse Model fully characterizes the entire humoral immune process - from antigen presentation and B-cell activation to antibody expression. This allows for a comprehensive understanding of immune responses during tumor development and treatment.
How Creative Biolabs' service Can Assist Your Projects
Why Choose Us
The Human PBMC-B Mouse Model addresses critical limitations present in traditional murine models. Conventional models often fall short in replicating human immune responses due to species-specific differences and the lack of human antibody involvement. Our innovative model includes immunodeficient mice co-engrafted with human PBMCs and tumor cells, thereby providing a more physiologically relevant platform for human-specific immunotherapy research.
| Key Features | Advantages |
|---|---|
| Realistic Immune Responses | The Human PBMC-B Mouse Model provides a more accurate simulation of human immune responses, including the secretion of human immunoglobulins (IgG), which begins around Day 22 post-PBMC injection. |
| Broad Applications | Our model is suitable for a range of pre-clinical applications, including: assessment of immunotherapy efficacy and safety, elucidation of autoimmune disease mechanisms, evaluation of viral immune responses, and exclusive leading technology. Built upon the latest research findings, our model stands as a unique technology of Creative Biolabs, offering cutting-edge technical support for various research endeavors. |
| Expert Support and Comprehensive Services | Our team comprises scientists with years of expertise in the field, ensuring robust professional support. From model establishment to comprehensive data analysis, Creative Biolabs provides a one-stop service tailored to specific research needs. |
To discuss your specific project needs - Get a quote today.
Customer Reviews
-
Confirmation of Complete Humoral Response
The utilization of Creative Biolabs' human PBMC-B mouse model has substantially advanced the evaluation of therapeutic antibody candidates by confirming both T-cell cytotoxicity and B-cell-mediated immunoglobulin G (IgG) secretion. The observed B-cell functionality within this platform is deemed markedly superior to that of standard PBMC systems previously employed. - Dr. L*a J**n. -
Superior Predictive Validity
Using Creative Biolabs' model for immuno-oncology study in our research has significantly improved the screening of our novel PD-1/CTLA-4 combination regimen. The consistent engraftment and stable GvHD management allowed us to complete the full dosing regimen, providing high-fidelity data that correlated strongly with our later research observations. - Prof. M*w H**g.
FAQs
What advantages does the Human PBMC-B Mouse Model offer over traditional models?
The Human PBMC-B Mouse Model includes active human antibody secretion and a full humoral immune response, providing richer and more relevant data compared to traditional PBMC and CD34+ HSC models.
How long can human B lymphocytes proliferate in the Human PBMC-B Mouse Model?
Following the injection of PBMCs, human B lymphocyte proliferation can be detected in the mouse spleen for over 35 days, with IgG secretion starting around Day 22.
Related Services
Human PBMC-NK Mouse Model for Immuno-Oncology Study
This model provides rapid engraftment of functional human NK cells alongside T cells, serving as a powerful preclinical tool to evaluate NK-cell-mediated therapies and ADCC-driven anti-tumor responses.
Learn More →Human PBMC-MHC KO Mouse Model for Immuno-Oncology Study
This model utilizes MHC-deficient hosts to significantly delay GvHD onset, providing an extended therapeutic window for longitudinal efficacy studies and mechanism-of-action evaluations of human-specific research compounds.
Learn More →How to Contact Us
Creative Biolabs remains committed to advancing immuno-oncology research by providing state-of-the-art humanized mouse models and comprehensive support services. For more information, contact us to leverage our expertise and enhance your research outcomes.
Reference
- Mian, Syed A et al. "Advances in Human Immune System Mouse Models for Studying Human Hematopoiesis and Cancer Immunotherapy." Frontiers in immunology vol. 11 619236. 2 Feb. 2021. Distributed under an Open Access license CC BY 4.0, without modification. https://doi.org/10.3389/fimmu.2020.619236
Download our brochureLoading case studies...
Online Inquiry